164 related articles for article (PubMed ID: 34120153)
1. The genetic architecture of Plakophilin 2 cardiomyopathy.
Dries AM; Kirillova A; Reuter CM; Garcia J; Zouk H; Hawley M; Murray B; Tichnell C; Pilichou K; Protonotarios A; Medeiros-Domingo A; Kelly MA; Baras A; Ingles J; Semsarian C; Bauce B; Celeghin R; Basso C; Jongbloed JDH; Nussbaum RL; Funke B; Cerrone M; Mestroni L; Taylor MRG; Sinagra G; Merlo M; Saguner AM; Elliott PM; Syrris P; van Tintelen JP; ; James CA; Haggerty CM; Parikh VN
Genet Med; 2021 Oct; 23(10):1961-1968. PubMed ID: 34120153
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.
Biernacka EK; Borowiec K; Franaszczyk M; Szperl M; Rampazzo A; Woźniak O; Roszczynko M; Śmigielski W; Lutyńska A; Hoffman P
J Appl Genet; 2021 Dec; 62(4):613-620. PubMed ID: 34191271
[TBL] [Abstract][Full Text] [Related]
3. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy.
van Tintelen JP; Entius MM; Bhuiyan ZA; Jongbloed R; Wiesfeld AC; Wilde AA; van der Smagt J; Boven LG; Mannens MM; van Langen IM; Hofstra RM; Otterspoor LC; Doevendans PA; Rodriguez LM; van Gelder IC; Hauer RN
Circulation; 2006 Apr; 113(13):1650-8. PubMed ID: 16567567
[TBL] [Abstract][Full Text] [Related]
4. Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.
Costa S; Medeiros-Domingo A; Gasperetti A; Akdis D; Berger W; James CA; Ruschitzka F; Brunckhorst CB; Duru F; Saguner AM
Circ Genom Precis Med; 2021 Feb; 14(1):e003047. PubMed ID: 33232181
[TBL] [Abstract][Full Text] [Related]
5. Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure.
Chen K; Rao M; Guo G; Duru F; Chen L; Chen X; Song J; Hu S
Europace; 2019 Jun; 21(6):970-977. PubMed ID: 30830208
[TBL] [Abstract][Full Text] [Related]
6. Population Prevalence of Premature Truncating Variants in Plakophilin-2 and Association With Arrhythmogenic Right Ventricular Cardiomyopathy: A UK Biobank Analysis.
Hylind RJ; Pereira AC; Quiat D; Chandler SF; Roston TM; Pu WT; Bezzerides VJ; Seidman JG; Seidman CE; Abrams DJ
Circ Genom Precis Med; 2022 Jun; 15(3):e003507. PubMed ID: 35536239
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.
Kannankeril PJ; Bhuiyan ZA; Darbar D; Mannens MM; Wilde AA; Roden DM
Heart Rhythm; 2006 Aug; 3(8):939-44. PubMed ID: 16876743
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion.
Sonoda K; Ohno S; Otuki S; Kato K; Yagihara N; Watanabe H; Makiyama T; Minamino T; Horie M
Europace; 2017 Apr; 19(4):644-650. PubMed ID: 28431057
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variant Score and Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Plakophilin-2 Mutation Carriers.
Svensson A; Platonov PG; Haugaa KH; Zareba W; Jensen HK; Bundgaard H; Gilljam T; Madsen T; Hansen J; Dejgaard LA; Karlsson LO; Gréen A; Polonsky B; Edvardsen T; Svendsen JH; Gunnarsson C
Cardiology; 2021; 146(6):763-771. PubMed ID: 34469894
[TBL] [Abstract][Full Text] [Related]
10. [The clinical analysis of plakophilin-2 gene mutation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia].
Liu X; Liu W; Hu D; Zhang L; Zhu T; Li C; Qiu X; Li L; Guo C; Liu X; Wang L; Zheng H; Wang C; Diao Q; Shi D; Zhan P; Deng Y; Liu K; Wang Y; Liu B; Liu H; Qin X; Lan Y
Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1001-6. PubMed ID: 26887364
[TBL] [Abstract][Full Text] [Related]
11. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
[TBL] [Abstract][Full Text] [Related]
12. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
[TBL] [Abstract][Full Text] [Related]
13. Incidentally identified genetic variants in arrhythmogenic right ventricular cardiomyopathy-associated genes among children undergoing exome sequencing reflect healthy population variation.
Headrick AT; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Penny DJ; Kim JJ; Landstrom AP
Mol Genet Genomic Med; 2019 Jun; 7(6):e593. PubMed ID: 30985088
[TBL] [Abstract][Full Text] [Related]
14. Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders?
Christensen AH; Benn M; Tybjaerg-Hansen A; Haunso S; Svendsen JH
Cardiology; 2010; 115(2):148-54. PubMed ID: 19955750
[TBL] [Abstract][Full Text] [Related]
15. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).
García-Quintáns N; Sacristán S; Márquez-López C; Sánchez-Ramos C; Martinez-de-Benito F; Siniscalco D; González-Guerra A; Camafeita E; Roche-Molina M; Lytvyn M; Morera D; Guillen MI; Sanguino MA; Sanz-Rosa D; Martín-Pérez D; Garcia R; Bernal JA
Nat Commun; 2023 Oct; 14(1):6461. PubMed ID: 37833253
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.
Joshi-Mukherjee R; Coombs W; Musa H; Oxford E; Taffet S; Delmar M
Heart Rhythm; 2008 Dec; 5(12):1715-23. PubMed ID: 19084810
[TBL] [Abstract][Full Text] [Related]
17. High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Hermida A; Fressart V; Hidden-Lucet F; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller DI; Rouanet S; Charron P; Gandjbakhch E
Eur J Heart Fail; 2019 Jun; 21(6):792-800. PubMed ID: 30790397
[TBL] [Abstract][Full Text] [Related]
18. Plakophilin 2A is the dominant isoform in human heart tissue: consequences for the genetic screening of arrhythmogenic right ventricular cardiomyopathy.
Gandjbakhch E; Charron P; Fressart V; Lorin de la Grandmaison G; Simon F; Gary F; Vite A; Hainque B; Hidden-Lucet F; Komajda M; Villard E
Heart; 2011 May; 97(10):844-9. PubMed ID: 21378009
[TBL] [Abstract][Full Text] [Related]
19. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.
Kirchner F; Schuetz A; Boldt LH; Martens K; Dittmar G; Haverkamp W; Thierfelder L; Heinemann U; Gerull B
Circ Cardiovasc Genet; 2012 Aug; 5(4):400-11. PubMed ID: 22781308
[TBL] [Abstract][Full Text] [Related]
20. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.
Carruth ED; Beer D; Alsaid A; Schwartz MLB; McMinn M; Kelly MA; Buchanan AH; Nevius CD; Calkins H; James CA; Murray B; Tichnell C; Matsumura ME; Kirchner HL; Fornwalt BK; Sturm AC; Haggerty CM
Circ Genom Precis Med; 2021 Apr; 14(2):e003302. PubMed ID: 33684294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
